Effect of Thesium Chinense Turczaninow on Breast Cancer Chemopreventive enzyme activity in In vitro |
Shon, Yun-Hee
(Intractable Diseases Research Center, College of Medicine, Dongguk University)
Kim, Mee-Kyung (Intractable Diseases Research Center, College of Medicine, Dongguk University) Park, Sun-Dong (Cardiovascular Medical Research Center and Department of Pharmacology, College of Medicine, Dongguk University) Nam, Kyung-Soo (Cardiovascular Medical Research Center and Department of Pharmacology, College of Medicine, Dongguk University) |
1 | Ries, L., Wingo, P.A., Miller, S.S., Howe, H., Weir, H.K., Rosenberg, H.M., Vernon, S.W., Cronin, K., Edwards, B.K. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88, 2398-2424, 2000 DOI ScienceOn |
2 | Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmaik, N. other National Surgical Adjuvant Breast and Bowel Project Investigators. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 18, 1371-1388, 1998 |
3 | Knowles, R.G., Moncada, S. Nitric oxide synthases in mammals. Biochem. J. 298, 249-258, 1994 DOI |
4 | Wink, D.A., Hanbauer, I., Grisham, M.B., Laval, F., Nims, R.W., Laval, J., Cook, J., Pacelli, R., Liebmann, J., Krishna, M., Ford, P.C., Mitchell, J.B. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell Regul. 34, 159-187, 1996 DOI |
5 | Green, J.E., Shibata, M.A., Shibata, E., Moon, R.C., Anver, M.R., Kelloff, G., Lubet, R. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Res. 61, 7449-7455, 2001 |
6 | Glikman, P., Vegh, J., Pollina, M.A., Mosto, A.H., Levy, C.M. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer (Phila) 60, 2237-2243, 1987 DOI ScienceOn |
7 | Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G., Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44, 1995 DOI ScienceOn |
8 | Vakkala, M., Kahlos, K., Lakari, E., Paakko, P., Kinnula, V., Soini, Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in situ and invasive breast carcinomas. Clin. Cancer Res. 6, 2408-2416, 2000 |
9 | Suh, N., Glasebrook, A.L., Palkowitz, A.D., Bryant, H.U., Burris, L.L., Starling, J.J., Pearce, H.L., Williams, C., Peer, C., Wang Y., Sporn, M.B. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. Cancer Res. 61, 8412-8415, 2001 |
10 | Tamir, S., Tannenbaum, S.R. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta. 1288, F31-F36, 1996 |
11 | Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., Harris, C.C. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 91, 86-88, 1999 DOI ScienceOn |
12 | Tschugguel, W., Knogler, W., Czerwenka, K., Mildner, M., Weninger, W., Zeillinger, R., Huber, J.C. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br. J. Cancer 74, 1423-1426, 1996 DOI ScienceOn |
13 | 康秉秀. 本草學, 永林社, 서울, p 169, 1991 |
14 | Kroncke, K.D., Fehsel, K., Suschek, C., Kolb-Bachofen, V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol. 1, 1407-1420, 2001 DOI ScienceOn |
15 | Huber, M., Poulin, R. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth. J. Clin. Endocrinol. Metab. 81, 113-123, 1996 DOI |
16 | 김동일. 鄕藥集成方, 여강출판사, 서울, p 152, 1991 |
17 | Li, L., Carol, T., Susan, K.G. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverse spontaneous tumors in ODC/Ras transgenic mice. Cancer Res. 60, 5696-5730, 2000 |
18 | Robbins, R.A., Barnes, P.J., Springall, D.R., Warren, J.B., Kwon, O.J., Buttery, L.D., Wilson, A.J., Geller, D.A., Polak, J.M. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Comm. 203, 209-218, 1994 DOI ScienceOn |
19 | Ambs, S., Hussain, S.P., Harris, C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11, 443-448, 1997 DOI |
20 | Macchiarini, P., Fontanini, G., Hardin, M.J., Squartini, F., Angeletti, C.A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340, 145-146, 1992 DOI ScienceOn |
21 | Manni, A., Astrow, S.H., Gammon, S., Thompson, J., Mauger, D., Washington, S. Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens. Breast Cancer Res. Treat. 67, 147-156, 2001 DOI ScienceOn |
22 | Marton, L.J., Pegg, A.E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35, 55-91, 1995 DOI ScienceOn |